How should a hypoechoic mass measuring about 3.4 × 3.5 × 3.5 cm in the left iliac fossa detected on abdominal and pelvic ultrasound be evaluated and managed?

Evaluation and Management of a 3.5 cm Hypoechoic Mass in the Left Iliac Fossa

For a hypoechoic mass of this size in the left iliac fossa, you should immediately perform a comprehensive transvaginal ultrasound with Doppler to characterize the mass, followed by MRI pelvis with contrast if the lesion remains indeterminate or shows suspicious features. 1

Initial Diagnostic Approach

Complete the Ultrasound Evaluation

Your initial abdominal-pelvic ultrasound has identified a hypoechoic mass, but this is insufficient for proper characterization. You must obtain:

• Transvaginal ultrasound with Doppler - This is the gold standard for adnexal mass evaluation and provides superior resolution compared to transabdominal imaging alone 1
• Color/Power Doppler assessment - Essential to evaluate vascularity of any solid components, as increased flow suggests malignancy 1

The location in the left iliac fossa suggests this could be:

• An adnexal/ovarian lesion
• A mesenteric/peritoneal mass
• A bowel-related lesion
• Epiploic appendagitis (though typically presents with acute pain) 2

Key Ultrasound Features to Document

During the comprehensive ultrasound, specifically assess:

• Echogenicity and internal architecture - Is it purely solid, cystic, or mixed?
• Margins - Smooth versus irregular (irregular margins have 93% PPV for malignancy) 1
• Solid components - Presence of papillary projections (>4 papillary structures are concerning) 1
• Doppler flow patterns - Increased color or spectral Doppler flow in solid tissue is worrisome 1
• Relationship to ovary and other structures - Determine the organ of origin

Risk Stratification Based on Ultrasound Findings

If the Mass Appears Indeterminate (Most Likely Scenario)

Indeterminate lesions are typically benign - malignancy risk is only 3.6-10.7% depending on classification system used 1. However, you cannot assume benignity without proper characterization.

Next step: MRI pelvis with and without IV contrast 1

• MRI has 96% overall accuracy for indeterminate adnexal lesion characterization 1
• Sensitivity 93.5%, specificity 96.6% using ADNEX MR scoring 1
• O-RADS MRI system yields 92% accuracy, 93% sensitivity, 91% specificity 1
• Contrast is crucial - it identifies enhancing solid tissue components that differentiate benign from malignant lesions 1

Alternative: Serial ultrasound follow-up may be appropriate if:

• The lesion appears to be an atypical hemorrhagic cyst
• Patient is premenopausal
• No suspicious features are present
• Follow-up interval: 8-12 weeks 1

If the Mass Shows Suspicious Features

Suspicious ultrasound features include:

• Irregular contour (93% PPV for malignancy) 1

• 4 papillary structures 1

• Solid tissue with increased Doppler flow 1
• Rapid growth on serial imaging

Immediate next step: MRI pelvis with contrast for definitive characterization before surgical planning 1

Do NOT order CT - CT has no role in characterizing adnexal masses when US and MRI are available 1. CT is only useful later for staging if malignancy is confirmed.

If the Mass Appears Benign

Certain benign patterns can be diagnosed confidently:

• Solid hypoechoic mass with smooth margins, acoustic shadowing, minimal Doppler flow - suggests ovarian fibroma/thecoma (common in postmenopausal women) 1
• Simple cyst, hemorrhagic cyst, dermoid, endometrioma - can be managed conservatively with surveillance

For small masses (<5 cm) with benign features in postmenopausal women, malignancy risk is only 1.3%, and all cancers showed growth by 7 months 1.

Management Algorithm

Premenopausal Patient:

1. Complete transvaginal US with Doppler
2. If indeterminate → MRI with contrast OR 8-12 week US follow-up
3. If suspicious → MRI with contrast → surgical consultation
4. If benign-appearing → surveillance ultrasound

Postmenopausal Patient:

1. Complete transvaginal US with Doppler
2. If indeterminate or suspicious → MRI with contrast (lower threshold for advanced imaging)
3. Consider tumor markers (CA-125) to aid risk stratification 3
4. Surgical consultation for any concerning features

Critical Pitfalls to Avoid

• Do not rely on transabdominal ultrasound alone - transvaginal imaging is mandatory for proper characterization 1
• Do not order CT for mass characterization - this wastes time and resources without adding diagnostic value 1
• Do not assume all hypoechoic masses are malignant - many benign lesions (fibromas, endometriomas) appear hypoechoic
• Do not skip Doppler assessment - vascularity is a key discriminator between benign and malignant lesions 1
• In postmenopausal women, maintain higher suspicion - even small masses warrant thorough evaluation 1

Special Considerations

If the mass proves to be non-adnexal (mesenteric, peritoneal, or bowel-related), CT may then become useful for surgical planning, but this determination requires complete ultrasound evaluation first 4.

For pregnant patients, the same ultrasound approach applies, but if MRI is needed, use MRI without contrast to avoid gadolinium exposure 1.